ArticleHealth and quality of life outcomes2026
An exploratory analysis of interaction effects in EQ-5D valuation using saturated EQ VAS datasets from the Netherlands, the United Kingdom, and China.
Article in Health and quality of life outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectivesTo examine whether interaction terms improve predictive accuracy in EQ-5D valuation models using fully saturated datasets, and to identify parsimonious interaction specifications that balance model performance and feasibility.
methodsA secondary analysis of three saturated EQ-5D visual analogue scale (VAS) datasets was conducted: EQ-5D-3 L from the Netherlands and the United Kingdom, and EQ-5D-5 L from China. The analysis followed three steps. First, main-effects models were estimated as a reference and compared with models including all second-order interaction terms. Second, the contribution of interaction terms was assessed by examining how model performance metrics (RMSE, R², AIC, and BIC) changed with the number of interaction terms included, and by ranking individual interaction terms according to their impact on RMSE across datasets. Third, parsimonious models using summary interaction terms were evaluated to capture key non-additive effects.
resultsIncluding interaction terms consistently improved predictive performance across all three datasets, although absolute improvements were modest. Interaction effects were strongest for combinations of severe health problems, and all interaction coefficients were positive, consistent with diminishing marginal utility. Interactions involving pain/discomfort and anxiety/depression were among the most influential across datasets. Parsimonious specifications incorporating summary interaction terms-N3D1 for EQ-5D-3 L and N45D1 for EQ-5D-5 L-captured much of the performance gain achieved by fully interacted models.
conclusionsInteraction effects are empirically detectable and systematically improve model performance in EQ-5D valuation when saturated data are available. Summary interaction terms provide a practical approach to capturing key non-additive effects while maintaining model parsimony.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.